KardiaMobile® 6L Versus 12-lead ECG: Effects on Clinic Utilization Time

Wiley.com

A Wiley study explored KardiaMobile 6L’s ability to shorten ECG collection time compared to standard 12L ECG without compromising data usability.

Composed of 100 patients, the study showed that approximately 3 minutes of room utilization time was saved with the 6L compared to the 12L, representing a 30% reduction in ECG acquisition time.

Formal integration of the 6L into clinic workflow would likely also cut down on further utilization time. If supported by larger randomized trials, the KardiaMobile 6L device should be considered for ECG collection when rhythm and intervals are the main priority.

Key Takeaways:

  • The average time saved for room utilization time with the KardiaMobile 6L is substantial and could help with patient satisfaction, physician satisfaction, and appropriate prescriptions
  • The 6L device proved an infrequent need for an additional 12L
  • KardiaMobile 6L can be particularly useful in areas where the 12L is not readily available and demonstrates more robust room utilization time in settings with less experienced MAs

Read Full Article

The Broad Impact of QT Monitoring: Extending Beyond Cardiac Health into Diverse Conditions

Beyond its traditional focus on cardiac-specific therapies, every investigational drug can potentially impact cardiac function. What if we expanded QT monitoring across various therapeutic areas?

KardiaMobile® 6L Versus 12-lead ECG: Effects on Clinic Utilization Time

Wiley.com | Clinic utilization time is significantly reduced with the KardiaMobile® 6L compared to traditional 12L ECG systems. This study published in Wiley highlights how the 6L minimizes the need for frequent conventional 12L use.

Remote Monitoring and Data Collection for Decentralized Clinical Trials

JAMAnetwork.com | Patient-centric trials require accessible digital health technologies. A JAMA study explores the current state and aspired role of remote monitoring and data collection tools in oncology trials.